There are multiple weight loss and diabetes medications that use either tirzepatide or semaglutide to treat type 2 diabetes or weight-related health conditions: Both Mounjaro and Zepbound are manufactured by Eli Lilly, while Wegovy and Ozempic are made by Novo Nordisk
Over the past weeks, CVS Health has highlighted digital and community-focused initiatives, including an AI-driven claims platform cutting processing time by over 20% and supporting a $20 billion digital innovation program
However, insulin can stimulate carnitine transport to skeletal muscle [272], which is associated with the upregulation of OCTN2 transcript levels [273]
Several GLP-1RAs, including semaglutide, have been shown to offer cardiovascular outcome benefit in people with T2D 33,34,35
Conclusion Incretins play an important role in normal glucose homeostasis, and incretin therapies should be considered in combination treatment regimens for patients with T2D from early onset to late disease
Read our real patient journey for month-by-month progression